Influenza mucosal vaccine (NanoBio)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza mucosal vaccine (NanoBio)
Drug Alias NameNanoStat muscosal influenza vaccineIntranasal seasonal influenza vaccineIntranasal nanoemulsion vaccine for influenzaTransmucosal influenza vaccine,Fluzone + 60%W805ECNB-1008
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBluewillow Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanobio CoBluewillow Biologics Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A